1 comment
47 forecasters
Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?
83%chance
No key factors yetAdd some that might influence this forecast.
Authors:
Opened:Nov 24, 2021
Closes:Dec 31, 2026
Scheduled resolution:Jan 1, 2027
Spot Scoring Time:Nov 26, 2021
